BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jul 17, 2026
Johnson & Johnson Tops Profit Expectations, Lifts Outlook Following Price… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
DOSE OF REALITY: REPORT FINDS BIG PHARMA CONTINUES TO SET OUT-OF-CONTROL LAUNCH PRICES ON NEW MEDICINES COMING TO MARKET
Jul 2, 2026
Reuters Analysis Finds Average Launch Price For Drugs Approved By FDA in 2025… Read More
THEY SAID IT! LAWMAKERS HIGHLIGHT IMPORTANCE OF GREATER COMPETITION TO LOWER PRESCRIPTION DRUG PRICES AT U.S. SENATE HELP COMMITTEE MARKUP
Jun 18, 2026
Lawmakers Advance Bipartisan Solutions to Hold Big Pharma Accountable for… Read More
SECOND OPINION: CLOSING LOOPHOLES BIG PHARMA EXPLOITS TO BLOCK COMPETITION AND KEEP DRUG PRICES HIGH WILL NOT UNDERMINE INNOVATION
Jun 16, 2026
Big Pharma’s Arguments Against Bipartisan, Market-Based Solutions to Foster… Read More
THEY SAID IT! LAWMAKERS AND EXPERTS SUPPORT BIPARTISAN, MARKET-BASED SOLUTIONS TO LOWER DRUG PRICES, FOSTER GREATER COMPETITION
Jun 5, 2026
U.S. House Judiciary Subcommittee Hearing Builds Bipartisan Momentum for ETHIC… Read More
THEY SAID IT! BROAD BASED SUPPORT FOR BIPARTISAN ETHIC ACT AND SKINNY LABELS, BIG SAVINGS ACT
Jun 2, 2026
Health Care Leaders and Policy Experts Agree Bipartisan, Market-Based… Read More
DOSE OF REALITY: AARP REPORT FINDS PRICES FOR TOP-SELLING BRAND NAME DRUGS RISE DRAMATICALLY IN THE U.S. WHILE FALLING IN OTHER COUNTRIES
Jun 2, 2026
Report Finds List Prices for Best-Selling Medicare Part D Prescription Drugs… Read More
THEY SAID IT! “HOW PHARMA WEAPONIZES A WORD TO EXTEND MONOPOLIES”
May 28, 2026
Big Pharma Hides Behind False Innovation Rhetoric to Maintain Rampant Abuse of… Read More
THEY SAID IT! R STREET: “RESTORING THE MARKET FOR LOWER PRICE DRUGS”
May 27, 2026
Analysis Details How Big Pharma’s Patent Abuse Delays Generic and Biosimilar… Read More
BIG PHARMA EARNINGS WATCH: PFIZER AND NOVO NORDISK
May 8, 2026
Pfizer CEO Highlights Delayed Competition on Blockbuster Drug as Reason to Be… Read More
Big Pharma Earnings Watch: AbbVie, GSK & AstraZeneca
Apr 30, 2026
AbbVie CEO Touts Patent Abuse to Extend Exclusivity on Blockbuster Skyrizi,… Read More
BIG PHARMA EARNINGS WATCH: SANOFI
Apr 27, 2026
Sanofi Touts Patent Thickets, Legal Strategy to Block Competition to Dupixent… Read More